OOIR: Observatory of International Research

Papers

(The H4-Index of Circulation-Cardiovascular Interventions is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Novel Antithrombotic Strategies After Surgical Bioprosthetic Valve Replacement	166
Adjunctive Imaging and Physiology During PCI Among Black and White Medicare Beneficiaries: Disparities in Utilization Patterns and Outcomes	100
The Beaten Path: Use of the Radial Artery as a Bypass Graft After Instrumentation	80
Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial	76
Impacts of Hospital Volume and Patient-Hospital Distances on Outcomes of Older Adults Receiving Percutaneous Microaxial Ventricular Assist Devices for Cardiogenic Shock	73
Age-Related Outcomes After Revascularization for Chronic Limb-Threatening Ischemia: An Analysis of BEST-CLI	67
Is Stable CAD the Same in All Circumstances? The Curious Case of PCI Before TAVR	64
Contemporary State-of-the-Art PCI of Left Main Coronary Artery Disease	61
Is There a Golden Hour for Thrombectomy in Intermediate-Risk Pulmonary Embolism? Insights From SYMPHONY-PE	54
Fatal Steam Pop Complicating Investigational SESAME Transcatheter Myotomy Using Off-the-Shelf Equipment	54
ACURATE neo2 Versus SAPIEN 3 Ultra Transcatheter Heart Valve in Severe Aortic Valve Calcification: A Propensity-Matched Analysis	54
Transcatheter Mitral Valve Replacement With Atrial Fixation for Treatment of Atrial Functional Mitral Regurgitation	54
Prospective Multicenter IDE Study of the Next-Generation Precision Aspiration Thrombectomy System for Intermediate-Risk Pulmonary Embolism: The SYMPHONY-PE Trial	53
Impact of Cerebral Embolic Protection Devices on Disabling Stroke After TAVR: Updated Results From the STS/ACC TVT Registry	46
Percutaneous Balloon–Expandable Stent Implantation to Treat Transverse Aortic Arch Obstruction: Medium- to Long-Term Outcomes of a Retrospective Multicenter Study	45
Perfect Wedding Between Patient With STEMI and Angiography-Derived Indexes of Coronary Physiology	44
Supplementing Randomized Trial Data to Answer a Real-World Question: Discharge to Home Status as a Heuristic for Stroke Severity After TAVR	42
Letter by Güner et al Regarding Article, “Clinical Outcomes of Percutaneous Transcatheter Release of Stuck Mechanical Mitral Valve With Cerebral Embolic Protection”	41
Temporal Trends in In-Hospital Outcomes Following Unprotected Left-Main Percutaneous Coronary Intervention: An Analysis of 14 522 Cases From British Cardiovascular Intervention Society Database 2009 t	38
Preventing Complications of Mechanical Circulatory Support Devices: The Clue for Improved Outcomes?	37
Angina After Percutaneous Coronary Intervention?	37
Visual Estimates of Coronary Slow Flow Are Not Associated With Invasive Wire-Based Diagnoses of Coronary Microvascular Dysfunction	37
Prognostic Implications of Bleeding and Ischemic Complications in Acute Myocardial Infarction-Related Cardiogenic Shock Managed With Microaxial Flow Pump	36
Giant Aberrant Vascular Structure Extending From the Left Ventricular Apex to the Umbilicus in a Newborn With Cantrell Pentalogy: Management and Transcatheter Closure	36
Response by Yamamoto et al to Letter Regarding Article, “Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention”	35

Efficacy of the Glucagon-Like Peptide-1 Agonist Exenatide in Patients Undergoing CABG or Aortic Valve Replacement: A Randomized Double-Blind Clinical Trial	35
Timing of Intervention and Long-Term Outcomes in Mild Congenital Heart Disease: A 35-Year Study From the Pediatric Cardiac Care Consortium	35
Timing of Complete Revascularization in Patients With STEMI and Multivessel Disease: An Updated Meta-Analysis of Randomized Clinical Trials	34
Letter by Skalidis et al Regarding Article, “Angiography-Derived Fractional Flow Reserve During Percutaneous Coronary Intervention”	34
Optimal Hemostatic Band Duration After Transradial Angiography or Intervention: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials	34
Intravascular Imaging for Optimal Left Main Percutaneous Coronary Intervention: A Requirement Rather Than an Option	33
Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions	33
Transcarotid Versus Surgical Aortic Valve Replacement for the Treatment of Severe Aortic Stenosis	32